Armistice Capital LLC Grows Position in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Armistice Capital LLC grew its stake in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 3.7% in the 4th quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 1,896,000 shares of the medical instruments supplier’s stock after buying an additional 68,195 shares during the period. DENTSPLY SIRONA accounts for 0.9% of Armistice Capital LLC’s investment portfolio, making the stock its 16th biggest position. Armistice Capital LLC’s holdings in DENTSPLY SIRONA were worth $67,479,000 as of its most recent filing with the SEC.

Other hedge funds also recently bought and sold shares of the company. Bar Harbor Wealth Management purchased a new position in DENTSPLY SIRONA during the fourth quarter worth $4,931,000. DAVENPORT & Co LLC purchased a new position in DENTSPLY SIRONA during the fourth quarter worth $1,220,000. Dimensional Fund Advisors LP increased its position in DENTSPLY SIRONA by 10.3% during the fourth quarter. Dimensional Fund Advisors LP now owns 2,122,355 shares of the medical instruments supplier’s stock worth $75,535,000 after buying an additional 197,431 shares in the last quarter. Andra AP fonden increased its position in DENTSPLY SIRONA by 20.3% during the third quarter. Andra AP fonden now owns 302,700 shares of the medical instruments supplier’s stock worth $10,340,000 after buying an additional 51,100 shares in the last quarter. Finally, Envestnet Asset Management Inc. boosted its holdings in shares of DENTSPLY SIRONA by 98.1% during the third quarter. Envestnet Asset Management Inc. now owns 347,220 shares of the medical instruments supplier’s stock worth $11,861,000 after purchasing an additional 171,958 shares during the last quarter. Hedge funds and other institutional investors own 95.70% of the company’s stock.

Insiders Place Their Bets

In related news, Director Gregory T. Lucier acquired 3,577 shares of DENTSPLY SIRONA stock in a transaction on Friday, May 31st. The shares were bought at an average price of $27.95 per share, for a total transaction of $99,977.15. Following the completion of the purchase, the director now directly owns 58,374 shares in the company, valued at approximately $1,631,553.30. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. 0.52% of the stock is currently owned by insiders.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on XRAY shares. StockNews.com cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a report on Friday, May 3rd. Leerink Partnrs restated an “outperform” rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. Needham & Company LLC decreased their price objective on DENTSPLY SIRONA from $42.00 to $36.00 and set a “buy” rating on the stock in a report on Friday, May 3rd. SVB Leerink started coverage on DENTSPLY SIRONA in a report on Monday, February 26th. They set an “outperform” rating and a $42.00 price objective on the stock. Finally, Robert W. Baird decreased their price objective on DENTSPLY SIRONA from $35.00 to $33.00 and set a “neutral” rating on the stock in a report on Friday, May 3rd. Five equities research analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. According to data from MarketBeat.com, DENTSPLY SIRONA presently has a consensus rating of “Moderate Buy” and a consensus price target of $35.22.

DENTSPLY SIRONA Trading Up 0.3 %

DENTSPLY SIRONA stock traded up $0.07 during midday trading on Wednesday, reaching $27.79. The stock had a trading volume of 298,314 shares, compared to its average volume of 3,259,709. DENTSPLY SIRONA Inc. has a twelve month low of $26.27 and a twelve month high of $41.65. The stock has a market capitalization of $5.77 billion, a PE ratio of -63.00, a price-to-earnings-growth ratio of 1.25 and a beta of 1.04. The company has a debt-to-equity ratio of 0.54, a quick ratio of 0.97 and a current ratio of 1.43. The stock’s 50-day simple moving average is $29.78 and its 200 day simple moving average is $32.42.

DENTSPLY SIRONA (NASDAQ:XRAY) last issued its quarterly earnings data on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, hitting analysts’ consensus estimates of $0.42. The company had revenue of $953.00 million for the quarter, compared to analysts’ expectations of $969.45 million. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The firm’s quarterly revenue was down 2.6% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.39 earnings per share. Analysts expect that DENTSPLY SIRONA Inc. will post 2.02 EPS for the current year.

DENTSPLY SIRONA Dividend Announcement

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 12th. Shareholders of record on Friday, June 28th will be paid a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.30%. The ex-dividend date is Friday, June 28th. DENTSPLY SIRONA’s dividend payout ratio is presently -145.45%.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.